FDA Approved: VANCOMYCIN HYDROCHLORIDE — Supplemental Application (Plano Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Vancomycin hydrochloride by Plano Pharmaceuticals Inc., approving changes to the approved drug product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacteremia
• Clostridioides Difficile-associated Diarrhea
• Endocarditis
• Intra-abdominal Infections
• Methicillin-resistant Staphylococcus Aureus Infections
• Osteomyelitis
• Pneumonia
• Skin and Soft Tissue Infections

Drugs mentioned

• VANCOMYCIN HYDROCHLORIDE (Vancomycin hydrochloride)

Snippet

SUPPL AP for VANCOMYCIN HYDROCHLORIDE (VANCOMYCIN HYDROCHLORIDE)